MedTrace Logo

A Healthy Female and Male Volunteers Aspirin Study

NCT01448031 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2012-05-10

No results posted yet for this study

Summary

This is a study to compare the bioavailability of Acetyl Salicylic Acid (ASA) between Esomeprazole and Aspirin after multiple dose administration.

Conditions

  • Healthy

Interventions

DRUG

Capsule ASA 81mg/esomeprazole 20mg

Multiple doses administered on Day 1 to 5

DRUG

Acetylsalicylzuur Apotex Cardio

Multiple doses administered on Day 1 to 5

Sponsors & Collaborators

Principal Investigators

  • Ronnie Beboso · BioKinetic Europe Ltd,14 Great Victoria Street,Belfast, N.Ireland,United Kingdom BT2 7BA

  • Tore Lind · AstraZeneca, Pepparedsleden 1 431 83 Molndal Sweden

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-04-30
Completion
2012-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01448031 on ClinicalTrials.gov